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Monday, March 2, 2009 371athe four important S4 arginine residues on the voltage-sensing paddle is still un-
known, with some models placing them in an aqueous crevice, and others a lipid
environment. To learn more about the intricate role of lipid in the structure and
function of potassium channels we have studied deuterium and phosphate
ESEEM on spin-labeled, liposome reconstituted KcsA. By scanning the
trans-membrane helices of KcsA, we show that deuterium coupling can be
used to determine residue depth within a lipid bilayer. In addition, residues
that interact with the phosphate head-groups of the lipid can be determined
by phosphate coupling, and their precise location modeled.
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Action Of Myosin-binding Protein C Mutations That Cause Hypertrophic
Cardiomyopathy
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Sarcomeric mutations in MyBPC that cause hypertrophic cardiomyopathy
(HCM) may act as dominant negative alleles by encoding ‘poison polypepti-
des’or as null alleles resulting in haploinsufficiency. To resolve this we have
studied left ventricular muscle samples from patients undergoing surgical
myectomy for obstructive HCM and compared these with samples from non-
failing (donor) heart muscle. Seven out of 27 myectomy samples were found
to contain mutations in MyBP-C: two previously described missense alleles
(Glu258Lys, Arg502Trp) and five premature terminations (truncating in do-
mains C3, C5, C7 [x2], C10). Western blots were performed using an antibody
shown to recognise specifically the N-terminal region (C0-C2) of MyBPC.
MyBPC content was quantified by ELC and densitometry and normalised to
staining with an anti-actin antibody.
No truncated peptides were detected in whole muscle homogenates, or the
myofibrillar fraction, of HCM tissue (including in overloaded gels). However,
the overall level of MyBP-C in myofibrils was reduced by 2454% in myofi-
brils from tissue containing a MyBP-C mutation: 0.76þ/-0.04 (n¼39) vs
1.00þ/-0.05 in non-failing (n¼19)* and 1.01þ/-0.05 (n¼24) in non-MyBPC
mutant myectomies. *p¼0.0005. Four of the myectomy samples individually
showed statistically significant differences from the non-failing group; these
included both truncation and missense samples.
The absence of detectable lower molecular weight protein suggests that the
truncated MyBPC proteins are degraded, arguing against their incorporation
in the myofibre and any dominant negative effect. In contrast, the lowered rel-
ative level of full length MyBPC in the myofibre argues strongly for haploin-
sufficiency as the disease mechanism (potentially for missense as well as trun-
cation alleles). Previous work on partial extraction of MyBPC suggests that
lowered MyBPC stoichiometry would be expected to alter muscle function.
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Cardiac TnT variants with abnormal splicing in the N-terminal region have
been found in avian and mammalian cases of dilated cardiomyopathy. Similar
abnormality also occurs in myopathic and failing human hearts. These cardiac
TnT variants may play a role in the pathogenesis and pathophysiology of car-
diomyopathy and heart failure. Without losses of function, the cardiac TnT var-
iants result in only minor differences in thin filament Ca2þ sensitivity. There-
fore, we hypothesize that the heterogeneity resulting from the presence of twoor more functionally distinct cardiac TnT variants in the normally uniform
adult cardiac muscle thin filaments desynchronizes myofilament activation
and decreases the contractile efficiency. We studied transgenic mouse hearts
expressing one or two of the myopathy-related cardiac TnT variants together
with the wild type adult cardiac TnT. The function of isolated working hearts
was examined for pumping efficiency in the absence of neurohumoral influ-
ence. The results showed that at heart rate of 480 beat per minute and pressure
load of 90 mmHg, contractile and relaxation velocities were lower in the trans-
genic mouse hearts than that in the wild type hearts. Left ventricular pumping
efficiency calculated by the ratio of ejection integral to total systolic integral
was also lower in the transgenic mouse hearts than that in wild type controls.
When stressed by pacing at 600 beats per minute and giving 10 nM isoproter-
enol, the transgenic mouse hearts exhibited shorter ejection time and decreased
cardiac efficiency than that of wild type hearts. These results indicate a chronic
pathogenic mechanism that TnT heterogeneity leads to decreased myocardial
efficiency due to desynchronized responses to intracellular Ca2þ transient.
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Cardiac myosin binding protein-C (cMyBP-C), long known to interact with
thick filaments, also interacts with thin filaments (actin) through its N-terminus.
However, a single actin binding site has not been identified and it is unclear
whether one or more N-terminal domains of cMyBP-C interact with actin. In
this study we aimed to characterize the interaction of the N-terminus of
cMyBP-C with actin using recombinant proteins consisting of various
cMyBP-C N-terminal domains. Results from high speed cosedimentation bind-
ing assays showed that recombinant proteins containing the C1 domain and the
MyBP-C motif bound to F-actin at a 1:1 molar ratio with a dissociation constant
(Kd) ~ 10 uM. In contrast, proteins containing either C1 or the motif showed
reduced binding at a 1:2 molar ratio. Proteins containing both C1 and the motif
also bundled actin filaments, suggesting multiple actin interaction sites. Bind-
ing of recombinant proteins to Ca2þ regulated thin filaments was similar to
binding to F-actin alone. Strongly bound myosin cross-bridges (myosin S1,
no ATP) abolished cMyBP-C binding to actin, while weakly bound cross-
bridges (myosin S1 plus ATP) diminished, but did not abolish, binding. Re-
combinant myosin DS2, which binds to the MyBP-C motif in vitro (~6 uM),
did not affect cMyBP-C binding to actin. However, phosphorylation of the mo-
tif or alkaline pH both reduced binding. Together, these results suggest that the
N-terminus of cMyBP-C contains at least two binding sites for actin and that
binding is modulated through electrostatic interactions. Supported by NIH
HL080367 to SPH and a NSF Graduate Research Fellowship to JFS.
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Background Mutations in the MYBPC3 gene, encoding for cardiac myosin
binding protein C (cMyBP-C), are a frequent cause of familial hypertrophic
cardiomyopathy (FHCM). In the present study we investigated if protein com-
position and function of the sarcomere are altered in a homogenous FHCM pa-
tient group with truncating mutations in MYBPC3 (MYBPC3mut).
Methods and Results Comparisons were made between cardiac samples from
MYBPC3 mutant carriers (c.2373dupG, n¼7; c.2864_2865delCT, n¼4) and
non-failing donors (n¼8). Western Immunoblotting using antibodies directed
against different parts of cMyBP-C did not reveal truncated cMyBP-C in
MYBPC3mut. Protein expression of cMyBP-C was significantly reduced in
MYBPC3mut by 3355%. Cardiac MyBP-C phosphorylation in MYBPC3mut
samples was similar to the values in donor samples, whereas the phosphoryla-
tion status of troponin I (cTnI) was reduced by 8455%, indicating divergent
phosphorylation of the two main contractile target proteins of the beta-adrener-
gic pathway. Force measurements in mechanically isolated Triton-per-
meabilized cardiomyocytes demonstrated a decrease in maximal force per
cross-sectional area of the myocytes in MYBPC3mut (21.453.9 kN/m
2) com-
pared to donor (34.551.7 kN/m2). Moreover, Ca2þ-sensititivy was higher
in MYBPC3mut (pCa50¼5.6050.04) than in donor (pCa50¼5.5250.03), con-
sistent with reduced cTnI phosphorylation. Treatment with exogenous protein
kinase A, to mimic beta-adrenergic stimulation, did not correct reduced
372a Monday, March 2, 2009maximal force, but abolished the initial difference in Ca2þ-sensititivy between
MYBPC3mut (pCa50¼5.4650.03) and donor (pCa50¼5.4850.02).
Conclusions Truncating MYBPC3 mutations cause haploinsufficiency, de-
ranged phosphorylation of contractile proteins and reduced maximal force gen-
erating capacity of cardiomyocytes. The enhanced Ca2þ-sensititivy in
MYBPC3mut is due to hypophosphorylation of troponin I secondary to muta-
tion-induced dysfunction.
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The giant protein titin is important for proper myofilament assembly and structure,
as well as the passive mechanical properties of the sarcomere. Within the sarco-
meric I-band region of titin reside two elastic elements - the cardiac specific
N2B element and the PEVK element. Unlike the N2B element that has been linked
to metabolism and signal transduction, the PEVK region has so far solely been re-
garded as a mechanical spring. Here we have used a loss of function approach to
delete exons 219-225 from the mouse titin gene, which encode all residues of the
PEVK element present in N2B titin, the main titin isoform expressed in the heart.
Homozygous PEVK knockout (KO) mice survived to adulthood and were fertile.
Titin-based passive tension was highly increased, accompanied by diastolic dys-
function, as determined by echocardiography, isolated heart experiments, and
muscle mechanics. Surprisingly, PEVK-KO mice had dilated and hypertrophied
hearts and had increased FHL2 expression, contrasting the cardiac atrophy and de-
creased FHL2 levels that result from the deletion of the N2B element. This work
indicates a concerted action of titin’s elastic elements in providing proper diastolic
function, but a distinct effect on the trophic properties of the heart.
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The sarcomeric titin springs influence myocardial distensibility and passive
stiffness. Titin-isoform composition and protein kinase-A-dependent titin phos-
phorylation are variables contributing to diastolic heart function. However, di-
astolic tone is lowered, left ventricular extensibility is increased, and relaxation
is accelerated also by activating protein kinase-G (PKG). Here we studied using
back-phosphorylation assays whether PKG can phosphorylate titin and affect
titin-based stiffness in skinned myofibers and isolated myofibrils. PKG in the
presence of 8-pCPT-cGMP (cGMP) phosphorylated the two main cardiac titin
isoforms, N2BA and N2B, in human donor and dog left ventricle. In human
myofibers/myofibrils dephosphorylated prior to mechanical analysis, passive
stiffness dropped 10-20% upon application of cGMP-PKG. Autoradiography
and anti-phosphoserine blotting of recombinant human I-band-titin domains es-
tablished that PKG phosphorylates titin’s N2-B and N2-A domains. Using site-
directed mutagenesis, a serine residue near the COOH-terminus of the cardiac
N2-B-unique sequence (N2-Bus) was identified as a PKG-phosphorylation site.
To address the mechanism of the PKG-effect on titin stiffness, single-molecule
AFM force-extension experiments were performed on engineered N2-Bus-con-
taining constructs. The presence of cGMP-PKG increased the bending rigidity
of the N2-Bus to a degree that explained the overall PKG-mediated decrease in
cardiomyofibrillar stiffness. Thus, the mechanically relevant site of PKG-in-
duced titin phosphorylation is most likely in the N2-Bus, whereas phosphory-
lation of other titin sites could affect protein-protein interactions. Results sug-
gest that reducing titin stiffness through PKG-dependent phosphorylation of the
N2-Bus can benefit diastolic function. Since failing human hearts revealed
lower PKG-mediated basal titin phosphorylation than donor hearts, titin-phos-
phorylation deficits may contribute to diastolic dysfunction in heart failure.1911-Plat
Proteasome Dysfunction in Troponin Related Cardiomyopathies
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Hypertrophic cardiomyopathy (HCM) is a disease characterized by small to
significant increases in calcium sensitivity of force development. Our results
suggest that patients with mutations which are associated with large increases
in calcium sensitivity of force development show poor prognosis. Investiga-
tion of two cardiac troponin T (cTnT) transgenic mice, I79N and F110I, which
are associated with HCM using a functional proteomics approach showed that
several key proteins which are known to be degraded by the proteasome are
altered when compared to wild-type cTnT transgenic mice. Skinned fiber stud-
ies from I79N and F110I transgenic mice showed that these mutations both
caused similar increases in calcium sensitivity of force development (change
in pCa50 ¼ approx. 0.22) when compared to wild-type transgenic mice. The
179N and F110I mice both showed significant decreases in 20S proteasome
activities related to wild-type cTnT transgenic mice suggesting that proteaso-
mal dysfunction may be a contributing factor to the pathogenesis of HCM.
The levels of polyubiquitinated proteins present in the I79N and F110I were
also increased relative to wild-type cTnT transgenic mice. Transgenic mice
expressing cTnT I79N or cTnT F110I do not develop significant hypertrophy
or ventricular fibrosis even after chronic exercise challenge. This suggests that
increased heart size may not the critical factor for causing proteasome dys-
function in some cardiomyopathies. These results suggest that the UPS is an
important system involved in the pathogenesis of troponin related HCM which
is initially caused by significant increases in calcium sensitivity of force devel-
opment.
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Engineering myocardium with specific contractile properties is a major goal of
cardiac regenerative medicine, both for in vivo therapy and in vitro disease
models. Yet maintaining the multiscale coupling and uniaxial orientation
from nanometer-scale actin-myosin motors to centimeter-scale muscle tissue
remains a major obstacle. Inspired by the collagen fibrillar network and cap-
illary beds in myocardium, we hypothesized that these microscale heterogene-
ities act as boundary conditions that direct cardiomyocyte alignment and func-
tional coupling. Specifically, our interest is the role these boundary conditions
play in the sub-cellular alignment of the sarcomeres. To tackle this problem
we developed a cardiac tissue engineering methodology that allows us to con-
trol and quantify sub-micron sarcomere orientation and measure macroscale
contractile force and electrical conduction. We evaluate the deformation of
2-dimensional (2D) myocardial sheets that mimic the lamellar layers of the
ventricular wall. Cardiomyocytes are grown onto a free-standing film of poly-
dimethylsiloxane elastomer, referred to as a muscular thin film (MTF). Micro-
scale heterogeneities are created using microcontact printing to direct 2D
myogenesis, either (i) isotropic with no cell or sarcomere alignment, (ii) aniso-
tropic with uniaxial cell and sarcomere alignment or (iii) an array of 20 mi-
crometer wide myocardial strands with enhanced uniaxial cell and sarcomere
alignment. For contractility experiments, MTFs are fashioned into cantilevers,
mounted in an organ bath and electrically stimulated at 0.5 Hz. Results dem-
onstrate that isotropic myocardium generates ~1 kPa peak systolic stress. In
stark contrast the anisotropic myocardium generates an order-of-magnitude
greater peak systolic stress of ~10 kPa. The 1D myocardial strands generate
the greatest peak systolic stress of ~17 kPa, or ~35 kPa when normalized
for muscle mass. This demonstrates that microscale heterogeneities can
have a profound effect on sarcomere alignment and muscle contractility, de-
fining new strategies for optimizing electro-mechanical function in engineered
muscle.
